18F-barbiturates are PET tracers with diagnostic potential in Alzheimer’s disease

Elisa Calamai, Sergio Dall’angelo, David Koss, Juozas Domarkas, Timothy J. McCarthy, Marco Mingarelli, Gernot Riedel, Lutz F. Schweiger, Andy Welch, Bettina Platt (Lead / Corresponding author), Matteo Zanda (Lead / Corresponding author)

    Research output: Contribution to journalArticlepeer-review

    9 Citations (Scopus)

    Abstract

    Three fluoro-barbiturates were synthesised, showing in vivo sedative efficacy. One of them, [18F]1a, was synthesised in radiofluorinated form. PET/CT Imaging with [18F]1a identified β-amyloid over-expressing transgenic mice (βA mice) compared to wild type and tau lines. The fluorescent barbiturate 9 was able to label βA plaques in brain sections of βA mice, and co-localise with a fluorescent Zn(II) indicator.

    Original languageEnglish
    Pages (from-to)792-794
    Number of pages3
    JournalChemical Communications
    Volume49
    Issue number8
    Early online date4 Dec 2012
    DOIs
    Publication statusPublished - 2013

    ASJC Scopus subject areas

    • Catalysis
    • Electronic, Optical and Magnetic Materials
    • Ceramics and Composites
    • General Chemistry
    • Surfaces, Coatings and Films
    • Metals and Alloys
    • Materials Chemistry

    Fingerprint

    Dive into the research topics of '18F-barbiturates are PET tracers with diagnostic potential in Alzheimer’s disease'. Together they form a unique fingerprint.

    Cite this